Skip to main content
Erschienen in: Pediatric Nephrology 7/2012

01.07.2012 | Letter to the Editor

Is it the right time to subject children with acute kidney injury to rasburicase trials?

verfasst von: Tomasz Jarmoliński, Marcin Zaniew, Joanna Tousty, Dariusz Runowski

Erschienen in: Pediatric Nephrology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Excerpt

Sirs, …
Literatur
1.
Zurück zum Zitat Acosta AA, Hogg RJ (2012) Rasburicase for hyperuricemia in hemolytic uremic syndrome. Pediatr Nephrol 27:325–329 Acosta AA, Hogg RJ (2012) Rasburicase for hyperuricemia in hemolytic uremic syndrome. Pediatr Nephrol 27:325–329
2.
Zurück zum Zitat Park SH, Shin WY, Lee EY, Gil HW, Lee SW, Lee SJ, Jin DK, Hong SY (2011) The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J 75:692–697PubMedCrossRef Park SH, Shin WY, Lee EY, Gil HW, Lee SW, Lee SJ, Jin DK, Hong SY (2011) The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J 75:692–697PubMedCrossRef
3.
Zurück zum Zitat Bosly A, Sonet A, Ross Pinkerton CR, McCowage G, Bron D, Sanz MA, Van den Berg H (2003) Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer. Report of an international compassionate use study. Cancer 98:1048–1054PubMedCrossRef Bosly A, Sonet A, Ross Pinkerton CR, McCowage G, Bron D, Sanz MA, Van den Berg H (2003) Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer. Report of an international compassionate use study. Cancer 98:1048–1054PubMedCrossRef
4.
Zurück zum Zitat Hobbs DJ, Steinke JM, Chung JY, Barletta GM, Bunchman TE (2010) Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol 25:305–309PubMedCrossRef Hobbs DJ, Steinke JM, Chung JY, Barletta GM, Bunchman TE (2010) Rasburicase improves hyperuricemia in infants with acute kidney injury. Pediatr Nephrol 25:305–309PubMedCrossRef
5.
Zurück zum Zitat Ghirardello S, Ardissino G, Mastrangelo A, Mosca F (2010) Rasburicase in the treatment of hyperuricemia of newborns. Pediatr Nephrol 25:1775PubMedCrossRef Ghirardello S, Ardissino G, Mastrangelo A, Mosca F (2010) Rasburicase in the treatment of hyperuricemia of newborns. Pediatr Nephrol 25:1775PubMedCrossRef
6.
Zurück zum Zitat Hooman N, Otukesh H (2011) Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: a report of 3 cases. IJKD 5:130–132PubMed Hooman N, Otukesh H (2011) Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: a report of 3 cases. IJKD 5:130–132PubMed
7.
Zurück zum Zitat Lin PY, Lin CC, Liu HC, Lee HC, Ho CS, Chiu NC, Peng CC, Huang FY, Tai JD (2011) Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke. Pediatr Crit Care Med 12(6):e424–e427PubMedCrossRef Lin PY, Lin CC, Liu HC, Lee HC, Ho CS, Chiu NC, Peng CC, Huang FY, Tai JD (2011) Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke. Pediatr Crit Care Med 12(6):e424–e427PubMedCrossRef
Metadaten
Titel
Is it the right time to subject children with acute kidney injury to rasburicase trials?
verfasst von
Tomasz Jarmoliński
Marcin Zaniew
Joanna Tousty
Dariusz Runowski
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 7/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-012-2127-7

Weitere Artikel der Ausgabe 7/2012

Pediatric Nephrology 7/2012 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.